Concepedia

Stephen Vinter

SV

Statistics

Publications

14

Citations

445

H-Index

13

Active since

2015

Affiliations

United States Food and Drug Administration(Current)

Bristol-Myers Squibb (United States)

Health Canada

Anis

Pfizer (United States)

Stephen Vinter is an author at United States Food and Drug Administration specializing in pharmacy, biopharmaceutics, and clinical bioanalysis.

Publications per year

2015–2025

14

Publications

14

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies)

Brad Ackermann, Hendrik Neubert, Nicola Hughes et al. · Bioanalysis · 2015 · 55 citations · Full text

, , +17

2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies)

An Song, Anita Lee, Fabio Garofolo et al. · Bioanalysis · 2016 · 43 citations · Full text

, , +16

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 1 – Small Molecules by LCMS)

Jan Welink, Eric Fluhler, Nicola Hughes et al. · Bioanalysis · 2015 · 42 citations · Full text

, , +15

2017 White Paper on Recent Issues in Bioanalysis: Aren’t Bmv Guidance/Guidelines ‘ <i>Scientific</i> ’? (Part 1 – LCMS: Small Molecules, Peptides and Small Molecule Biomarkers)

Jan Welink, Eric Yang, Nicola Hughes et al. · Bioanalysis · 2017 · 41 citations · Full text

, , +15

2018 White Paper on Recent Issues in Bioanalysis: <i>‘A Global Bioanalytical Community Perspective on Last Decade of Incurred Samples Reanalysis (ISR)’</i> (Part 1 – Small Molecule Regulated Bioanalysis, Small Molecule Biomarkers, Peptides &amp; Oligonucleotide Bioanalysis)

Jan Welink, Yuanxin Xu, Eric Yang et al. · Bioanalysis · 2018 · 39 citations · Full text

, , +16

1–5 of 14